Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) - Pipeline Review, H1 2016 - Global Markets Direct - Market Research

Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) - Pipeline Review, H1 2016

Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) - Pipeline Review, H1 2016 - Global Markets Direct - Market Research
Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) - Pipeline Review, H1 2016
Published Jun 30, 2016
59 pages — Published Jun 30, 2016
Price US$ 3,500.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Global Markets Directs, Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) - Pipeline Review, H1 2016, provides in depth analysis on Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) targeted pipeline therapeutics.

The report provides comprehensive information on the Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1), targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) targeted therapeutics development and features dormant and discontinued projects.

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the global therapeutic landscape for Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1)
- The report reviews Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) targeted therapeutics and enlists all their major and minor projects
- The report assesses Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- Th

  
Source:
Document ID
GMDHC0217TDB
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents24
  List of Tables51
  List of Figures51
Introduction61
  Global Markets Direct Report Coverage61
Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Overview71
Therapeutics Development84
  Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Products under Development by Stage of Development81
  Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Products under Development by Therapy Area91
  Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Products under Development by Indication102
Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Pipeline Products Glance122
  Late Stage Products121
  Early Stage Products131
Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Products under Development by Companies143
Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Therapeutics Assessment176
  Assessment by Monotherapy/Combination Products171
  Assessment by Mechanism of Action181
  Assessment by Route of Administration192
  Assessment by Molecule Type212
Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Companies Involved in Therapeutics Development237
  Anacor Pharmaceuticals, Inc.231
  Astex Pharmaceuticals, Inc.241
  BioAxone BioSciences, Inc.251
  HitGen LTD261
  Kadmon Corporation, LLC271
  Vertex Pharmaceuticals Incorporated281
  Vichem Chemie Research Ltd.291
Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Drug Profiles3016
  AN-3485 Drug Profile301
  AT-13148 Drug Profile312
  BA-1049 Drug Profile331
  KD-025 Drug Profile344
  KL-00148 Drug Profile381
  KL-00199 Drug Profile391
  Small Molecule to Inhibit Rho-associated protein kinase 2 Drug Profile401
  Small Molecule to Inhibit ROCK-2 for Cardiovascular, Ophthalmology and Oncology Drug Profile411
  TRN-101 Drug Profile421
  VX-210 Drug Profile433
Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Dormant Projects461
Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Discontinued Products471
Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) Featured News &Press Releases4810
  Jun 03, 2016: Kadmon Initiates Phase 2 Clinical Trial Evaluating KD025 in Idiopathic Pulmonary Fibrosis481
  Mar 21, 2016: Kadmon Announces Publication of Data Demonstrating the Potential of ROCK2 Inhibition to Treat Chronic Graft-Versus-Host Disease481
  Feb 25, 2016: Kadmon to Present Preclinical Data Demonstrating ROCK2 Signaling as a Key Regulator of T Follicular Helper Cell Function in Autoimmune Conditions491
  Feb 08, 2016: BioAxone BioSciences Announces NIH/SBIR Fast Track Grant to Develop BA-1049 for Treatment of Cerebral Cavernous Malformation/Angioma501
  Jan 11, 2016: Kadmon to Present Preclinical Data Demonstrating the Importance of ROCK2 Signaling in Modulating Immune Response511
  Jun 22, 2015: Kadmon Presents Data Demonstrating Potential of ROCK2 Inhibition to Treat Lupus511
  May 06, 2015: Kadmon Presents Data on Role of ROCK2 Inhibition at AAI Annual Meeting521
  Feb 09, 2015: Kadmon Announces Publication Highlighting Importance of ROCK2 in Autoimmunity531
  Jan 06, 2015: Kadmon Initiates Phase 2 Clinical Trial Evaluating KD025 in Psoriasis531
  Dec 11, 2014: Kadmon Corporation s KD025 Named a Top Priority Lupus Treatment Candidate by the Alliance for Lupus Research and the Lupus Research Institute541
  Dec 08, 2014: Kadmon Corporation Presents Preclinical Data on KD025 in Chronic Graft-Versus-Host-Disease at American Society of Hematology Annual Meeting541
  Nov 10, 2014: Kadmon Researchers Define Importance of ROCK2 Signaling Pathway in Human Autoimmune Response551
  May 05, 2014: Kadmon Corporation Presents Results of KD025 Preclinical and Clinical Studies at AAI Annual Meeting561
  Apr 08, 2014: Kadmon Corporation Announces the Initiation of KD025 Phase 2 Program in Psoriasis561
  Mar 27, 2014: Kadmon Corporation Presents Results at the 9th International Congress on Autoimmunity Demonstrating the Effects of KD025 on Immune Homeostasis571
Appendix582
  Methodology581
  Coverage581
  Secondary Research581
  Primary Research581
  Expert Panel Validation581
  Contact Us581
  Disclaimer591

Table Of Contents

Global Markets Direct - Market Research—Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information.

About the Author


Cite this Report

  
MLA:
Global Markets Direct - Market Research. "Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) - Pipeline Review, H1 2016" Jun 30, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Rho-Associated-Protein-Kinase-2-Rho-Kinase-2-or-Rho-Associated-Coiled-Coil-Containing-Protein-Kinase-2-or-p164-ROCK-2-or-EC-2-7-11-1-Pipeline-Review-H1-2016-2088-16107>
  
APA:
Global Markets Direct - Market Research. (2016). Rho-Associated Protein Kinase 2 (Rho Kinase 2 or Rho-Associated, Coiled-Coil-Containing Protein Kinase 2 or p164 ROCK-2 or EC 2.7.11.1) - Pipeline Review, H1 2016 Jun 30, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/Global-Markets-Direct-Market-Research/Rho-Associated-Protein-Kinase-2-Rho-Kinase-2-or-Rho-Associated-Coiled-Coil-Containing-Protein-Kinase-2-or-p164-ROCK-2-or-EC-2-7-11-1-Pipeline-Review-H1-2016-2088-16107>
  
US$ 3,500.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.